March 23, 2023

Wyden Announces Finance Committee Hearing on Pharmacy Benefit Managers and the Prescription Drug Supply Chain

WASHINGTON, D.C. – Senate
Finance Committee Chair Ron Wyden
, D-Ore., will convene a committee hearing
on
Thursday, March 30,
2023 titled “Pharmacy Benefit Managers and the
Prescription Drug Supply Chain: Impact on Patients and Taxpayers.”
The hearing will take place at
10:00 a.m. in
Room 215 of the Dirksen Senate Office Building.

 

The witnesses at Thursday’s hearing will be:


  • Robin Feldman, J.D., Arthur J. Goldberg Distinguished
    Professor of Law and Director of the Center for Innovation, University of
    California Hastings College of Law

  • Karen Van Nuys, PhD, Executive Director, Value of Life
    Sciences Innovation, University of Southern California Leonard D.
    Schaeffer Center for Health Policy & Economics

  • Lawton Robert Burns, PhD, James Joo-Jin Kim Professor
    of Health Care Management and Co-Director of the Roy & Diana Vagelos
    Program in Life Sciences & Management, Wharton School, University of
    Pennsylvania

  • Matthew Gibbs, Pharm.D., President, Capital Rx

  • Jonathan E. Levitt, Esq., Founding Partner, Frier
    Levitt Attorneys at Law

 

Who:    
Senate Finance Committee

What:  
Committee hearing
on
pharmacy benefit managers and the prescription drug supply chain’s impact on
patients and taxpayers.

Where: 215
Dirksen Senate Office Building

             
Washington, D.C. 20510

When:
Thursday, March 30, 2023

            
10:00 a.m.

 

Media are encouraged to attend
the hearing or to view the webcast and witness testimony at
http://www.finance.senate.gov/hearings
.

 

###

Print 
Email 
Share 
Share